Delivery Order SPE2DB24D1205-SPE2DB25FCZAJ
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,966.67 by the Defense Logistics Agency (DLA) on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract is for the supply of Actemra ActPen 162 mg/0.9 ml pharmaceutical product under firm fixed pricing with no set-aside designation. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $48,698.09 delivery order to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 mL pharmaceutical supplies. This firm fixed price, competitively awarded contract was executed on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework...
- The Defense Logistics Agency awarded a delivery order valued at approximately $51,886 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen (162 mg/0.9 mL) pharmaceutical product, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract was issued on July 24, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The award includes no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order valued at $19,253.01 to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 mL pharmaceutical supplies. The contract, executed on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing and represents a non-set-aside competitive award. Performance will be conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,672.79 for Actemra Actpen 162 mg/0.9 mL pharmaceutical product, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $5,863.20 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Actemra Actpen (162 mg/0.9 mL) pharmaceutical product. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was awarded competitively with no set-aside designation. This delivery order is issued under AmerisourceBergen...
- The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. This $6,243.29 contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceutical products. The contract has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $8,032.48 delivery order is for ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceuticals, with a completion date of January 16, 2024. This order is part of AmerisourceBergen Drug Corp's existing indefinite delivery contract with DLA Troop Support Medical to provide...
- The Defense Logistics Agency awarded a $8,021.19 delivery order to AmerisourceBergen Drug Corp for ACTEMRA ACTPEN 162 MG/0.9 ML pharmaceutical product, with a completion date of July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply portfolio supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $11,196.02 to AmerisourceBergen Drug Corp for 4,568,895,450 units of Actemra 400 mg/20 mL vials on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract utilizes firm fixed pricing with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award under AmerisourceBergen's existing Indefinite...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZAJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,609.13 to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 mL pharmaceutical product. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of July 30, 2025. The award was made on July 29, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. The company's contract portfolio demonstrates extensive experience delivering a comprehensive range of pharmaceutical products, including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for Actemra, a specialty pharmaceutical used in rheumatoid arthritis treatment, reflects the company's ongoing role in supplying essential medications to support Defense Health Agency and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 7/29/25 |